A Study to Compare a New Eye Drop Formulation With Systane® Gel Drops and Genteal® Lubricant Gel Drops for Moderate to Severe Dry Eye Relief

Study Identifier
11193X-002
CT.gov Identifier
NCT02455050
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Dry Eye
    • Study Drug
  • Carboxymethylcellulose Sodium Based Eye Drops
  • Systane® Gel Drops
  • Genteal® Lubricant Gel Drops
    • Phase
    Phase 3
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Current use of an artificial tear product * Visual Acuity of at least 20/40 (while wearing glasses, if necessary).
    Exclusion Criteria:
    * Use of contact lenses in the last 3 months, or anticipated use of contact lenses during the study * Cataract surgery, laser-assisted in situ keratomileusis (LASIK), photorefractive keratectomy within 6 months * Use of RESTASIS® Cyclosporine Ophthalmic Emulsion or any topical cyclosporine within 3 months * Diagnosis of glaucoma.

    Protocol Summary

    A study to evaluate the tolerability and acceptability of an investigational eye drop formulation in patients with Dry Eye Disease.

    Study Locations

    Location
    Status
    Location
    Azusa, California, United States
    Status
    Not applicable